Abstract:Objective To investigate the expression of platelet-derived circular RNA hsa_circ_0001535 and to analyze its correlation with antiplatelet reactivity in patients with acute coronary syndrome (ACS) after dual antiplatelet therapy. Methods A total of 169 consecutive ACS patients hospitalized in the Department of Cardiology of Chinese PLA General Hospital between October 2020 and March 2022 and treated with aspirin combined with a P2Y12 receptor antagonist were enrolled. All patients underwent thromboelasto-graphy (TEG) after receiving a single dose of dual antiplatelet therapy. Adenosine diphosphate (ADP)-induced platelet-fibrin clot strength (MAADP) of platelet-fibrin clot strength and ADP-induced platelet inhibition rate (PIADP) were used to reflect antiplatelet reactivity. With PIADP 75% as the cutoff value, patients were divided into a low on-treatment platelet reactivity group (LTPR group, n=106, PIADP > 75%) and a high on-treatment platelet reactivity group (HTPR group, n=63, PIADP≤ 75%). Platelet RNA was extracted from peripheral whole blood, and the relative expression level of hsa_circ_0001535 in platelets was detected by fluorescent quantitative multiplex polymerase chain reaction (PCR). Data analysis was performed using SPSS 27.0 and R language version 4.4.2. Based on data type, intergroup comparisons were conducted using the t-test, Wilcoxon rank-sum test, orχ2 test. Multivariate logistic regression analysis revealed that age (OR=1.07,95%CI 1.02-1.13; P=0.0071), body mass index (OR=0.82,95%CI 0.72-0.94; P=0.0030), platelet-derived hsa_circ_0001535 (OR=1.22,95%CI 1.04-1.43; P=0.0160) , clopidogrel (OR=2.45,95%CI 1.12-5.35; P=0.0242), and CYP2C19 loss-of-function (OR=1.24,95%CI 1.01-1.51; P=0.0421) were independent factors affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients. Results In the 169 patients, the median relative expression level of platelet-derived hsa_circ_0001535 was 1.47 (0.83,2.66), the median MA ADP was 19.40 (10.63,31.18), and the median PI ADP was 88.20% (55.04%, 94.55%), all showing a skewed distribution. Spearman correlation analysis found that the relative expression level of platelet-derived hsa_circ_0001535 was negatively correlated with PI ADP (r=-0.16, P=0.039). The expression level of platelet-derived hsa_circ_0001535 was significantly higher in the HTPR group than that in the LTPR group [1.94 (1.15,3.76) vs. 1.28 (0.59,2.14); P=0.0006)]. Multivariate logistic regression analysis revealed that platelet-derived hsa_circ_0001535 was an independent factor affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients (OR=1.22,95%CI 1.04-1.43; P=0.0160). Conclusion The relative expression level of platelet-derived hsa_circ_0001535 is independently correlated with antiplatelet reactivity in ACS patients after dual antiplatelet therapy.